Hematological Disorders Diagnostic and Therapeutic Market:

Global Industry Analysis and Forecast 2014 - 2020

Persistence Market Research

Hematological Disorders Diagnostic and

Therapeutic Market: Global Industry Analysis
and Forecast 2014 - 2020

Persistence Market Research

Hematological Disorders Diagnostic and Therapeutic Market:

Global Industry Analysis and Forecast 2014 - 2020

Persistence Market Research Released New Market Report on Hematological Disorders

Diagnostic and Therapeutic Market: Global Industry Analysis and Forecast 2014 - 2020.
Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of
blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells
(WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes, and proteins involved in
bleeding and clotting processes. People can be affected by many different types of blood
disorders. Major blood disorders that affect people include anemia, bleeding disorders, and
blood cancer. Hemophilia and thrombosis are the most common types of bleeding disorders.
Leukemia, lymphoma, and myeloma are the major types of blood cancer. Leukemia is caused
by the rapid production of abnormal WBCs, and occurs in the blood and bone marrow. It is
mainly classified as chronic myeloid leukemia, acute myeloid leukemia, acute lymphocytic
leukemia, and chronic lymphocytic leukemia. Lymphoma affects the lymphatic system of the
human body. Hodgkin lymphoma and non-Hodgkin lymphoma are the common types of
lymphoma. Myeloma specifically affects plasma cells. Myeloma is mainly classified as multiple
myeloma and myelodysplastic syndrome.
Buy full report : http://www.persistencemarketresearch.com/marketresearch/hematological-disorders-diagnostic-therapeutic-market.asp
In terms of geography, North America dominates the global hematological disorders diagnostic
and therapeutic market. This is due to increased awareness about blood diseases and
technological advancement in diagnostic procedures in the region. The U.S. represents the
largest market for hematological disorders diagnostic and therapeutic in North America,
followed by Canada. In Europe, Germany, France, the U.K., Italy and Spain account for a major
share of the hematological disorders diagnostic and therapeutic market. This market in Asia is
expected to expand at a significant rate over the next five years. This is due to various
companies setting up manufacturing facilities in the region. Moreover, increasing awareness
about blood disorders and rise in geriatric population are also driving the growth of the market
in the region. India, China and Japan are expected to be the fastest growing hematological
disorders diagnostic and therapeutic markets in Asia.

In recent times, increased demand of diagnostic and therapeutic products for the management
of blood diseases is key driver of the global hematological disorders diagnostic and therapeutic
market. Increased investments in R&D in the pharmaceutical sector, lack of curative drugs for

Persistence Market Research

Hematological Disorders Diagnostic and Therapeutic Market:

Global Industry Analysis and Forecast 2014 - 2020
blood diseases, and the introduction of innovative drugs have also fueled the growth of this
market. The ongoing development of drugs with properties, such as improved safety and high
patient compliance, are also supporting the growth of the global hematological disorders
diagnostic and therapeutic market. Therapies such as biological therapy, physiotherapy,
chemotherapy, and radiation therapy have immense potential to spur the growth of this
market.

However, stringent regulations by various governments hamper the growth of global

hematological diagnostic and therapeutic market. Moreover, the patent expiries of some
blockbuster drugs (drugs that have an annual sale of USD 1.0 million and above) have
hindered the growth of the market. Increasing mergers and acquisitions of drug manufacturing
companies and rapid product launches are some of the major trends in the global
hematological diagnostic and therapeutic market.

The major companies operating in this market are Abbott Laboratories, Amgen, Baxter
Healthcare Corporation, Bayer Healthcare Pharmaceuticals, Biogen Idec, Inc., Bristol-Myers
Squibb, C.R. Bard, Inc, Eli Lilly and Company, GE Healthcare, GlaxoSmithKline, Pfizer, Sanofi,
Siemens AG, and Teva Pharmaceutical Industries Ltd.

Request full TOC: http://www.persistencemarketresearch.com/toc/4096

Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc
(as applicable)
2. The report covers geographic segmentation
North America
Europe
Asia
RoW
3. The report provides the market size and forecast for the different segments and
geographies for the period of 2010 to 2020
4. The report provides company profiles of some of the leading companies operating in the
market
5. The report also provides porters five forces analysis of the market.
Browse the full All Upcoming Persistence Market's report at
http://www.persistencemarketresearch.com/forthcoming-reports.asp

Persistence Market Research

Hematological Disorders Diagnostic and Therapeutic Market:

Global Industry Analysis and Forecast 2014 - 2020

About Us:
Persistence Market Research is a global market research firm specializing- syndicated
research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business.
As a full-service market research firm, we stand committed to bringing more accuracy and
speed to your business decisions. From ready-to-purchase market research reports to
customized global research solutions, our engagement models are highly flexible without
compromising on our deep-seated research values. Briefly stated, our mission is to give you
access to forecasts and trends analyses that put you on the path to profitability.
PMRs Services Go Beyond Gleaning Data:
Most enterprises believe that IT and databases are enough to make an accurate decision. While
we do not dispute that, consider this: How long does it take to make an accurate and strategic
million-dollar decision? We strive to deliver both even with demanding deadlines.

Facilitating Rapid and Informed Business Decisions

PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by
carefully balancing traditional and modern-day research methodologies.
Contact Us:
Addie Thomes
305 Broadway,
7th Floor,
New York City, NY 10007,
United States.
Phone: +1-646-568-7751
USA/Canada Toll Free Number.
1-800-961-0353
E-mail: Sales@persistencemarketresearch.com
Web : http://www.persistencemarketresearch.com/

Persistence Market Research